Regional pandemic beneficiaries tanking; analysts see worst yet to come
GLOVEMAKERS in Singapore and Malaysia, as well as personal protective equipment maker Medtecs International : 546 0%, have suffered hits in terms of profitability and market values amid the easing of the coronavirus pandemic.
These counters booked record-high profit and revenue figures during the height of the pandemic. Their share prices rose as new virus variants were discovered and investors piled into the stocks.
But with the roll-out of vaccines and easing of restrictions on capacity limits and group sizes, the prospects for these companies are dimming.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
US holds quarterly debt sale steady, starts buybacks this month
US dollar nears six-month high after pre-Fed data shock, yen steady
KFC parent Yum reports surprise drop in global same-store sales on weak demand
Pfizer lifts 2024 profit view on cost cuts, higher Covid vaccine demand
Shell exits China power market businesses
DuPont beats profit estimates, raises full-year forecasts